BRIEF published on 01/16/2026 at 18:05, 2 months 6 days ago Fermentalg Announces 2026 Financial Agenda Financial Agenda FERMENTALG Aquatic Microorganisms 2026 Results BioSolutions
BRIEF published on 01/16/2026 at 18:05, 2 months 6 days ago Fermentalg unveils its financial agenda for 2026 Financial Results Euronext Growth FERMENTALG BioSolutions Financial Calendar 2026
BRIEF published on 01/16/2026 at 18:05, 2 months 6 days ago PREDILIFE's Half-Yearly Review of Liquidity Contract Liquidity Contract Personalized Medicine PREDILIFE Semi-annual Transactions Financial Economy
BRIEF published on 01/16/2026 at 17:55, 2 months 6 days ago Westwing Group SE Raises 2025 EBITDA Guidance Financial Performance Annual Report Westwing Group SE Revenue Guidance 2025 EBITDA
BRIEF published on 01/16/2026 at 17:52, 2 months 6 days ago HBM Healthcare Investments AG Releases Key Figures for January 2026 Key Figures Share Price HBM Healthcare 2026 Performance Nav Value
BRIEF published on 01/16/2026 at 17:50, 2 months 6 days ago Peugeot Invest Reports on Liquidity Contract Performance Liquidity Contract PEUGEOT INVEST Investment Strategy ODDO BHF Share Transactions
BRIEF published on 01/16/2026 at 17:50, 2 months 6 days ago Voting rights and share capital of AUGROS COSMETIC PACKAGING as of December 31, 2025 Euronext Paris Voting Rights Investors Actions Augros
BRIEF published on 01/16/2026 at 17:45, 2 months 6 days ago Elis Ends Liquidity Contract with Oddo BHF Financial Results Liquidity Contract Share Buyback ODDO BHF Elis
BRIEF published on 01/16/2026 at 17:45, 2 months 6 days ago Elis terminates its liquidity contract with Oddo BHF Liquidity Contract Share Buyback ODDO BHF Elis Circular Services
BRIEF published on 01/16/2026 at 17:17, 2 months 6 days ago Kering Reports Updated Shares and Voting Rights for January 2026 Voting Rights Shares AMF Kering January 2026
Published on 03/23/2026 at 08:00, 1 hour 33 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 7 hours 33 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 09:19, 14 minutes ago Mister Spex Chooses Salesforce to further develop its Omnichannel Strategy
Published on 03/23/2026 at 09:00, 33 minutes ago EQS Group launches Risk Management module to support continuous data and AI risk oversight
Published on 03/20/2026 at 19:00, 2 days 14 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 15 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 2 days 16 hours ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 15 hours ago Filing of the 2025 Universal Registration Document